Contribution of whole genome sequencing in the molecular diagnosis of mosaic partial deletion of the NF1 gene in neurofibromatosis type 1.

MLA

Pacot, Laurence, et al. “Contribution of Whole Genome Sequencing in the Molecular Diagnosis of Mosaic Partial Deletion of the NF1 Gene in Neurofibromatosis Type 1.” Human Genetics, vol. 142, no. 1, Jan. 2023, pp. 1–9. EBSCOhost, https://doi.org/10.1007/s00439-022-02476-3.

APA

Pacot, L., Pelletier, V., Chansavang, A., Briand-Suleau, A., Burin des Roziers, C., Coustier, A., Maillard, T., Vaucouleur, N., Orhant, L., Barbance, C., Lermine, A., Hamzaoui, N., Hadjadj, D., Laurendeau, I., El Khattabi, L., Nectoux, J., Vidaud, M., Parfait, B., Dollfus, H., & Pasmant, E. (2023). Contribution of whole genome sequencing in the molecular diagnosis of mosaic partial deletion of the NF1 gene in neurofibromatosis type 1. Human Genetics, 142(1), 1–9. https://doi.org/10.1007/s00439-022-02476-3

Chicago

Pacot, Laurence, Valerie Pelletier, Albain Chansavang, Audrey Briand-Suleau, Cyril Burin des Roziers, Audrey Coustier, Theodora Maillard, et al. 2023. “Contribution of Whole Genome Sequencing in the Molecular Diagnosis of Mosaic Partial Deletion of the NF1 Gene in Neurofibromatosis Type 1.” Human Genetics 142 (1): 1–9. doi:10.1007/s00439-022-02476-3.